CTKB Stock-Based Compensation
Cytek Biosciences Inc · Stock-Based Compensation
CTKB Stock-Based Compensation
Latest reported$5.34Mperiod ending
CTKB Quarterly Stock-Based Comp ($105.00K → $5.34M)
Quarterly stock-based compensation
High-resolution chart · PNG
CTKB stock-based compensation history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 5,339,000 | |
| 4,861,000 | |
| 5,527,000 | |
| 5,638,000 | |
| 6,790,000 | |
| 6,630,000 | |
| 7,003,000 | |
| 7,053,000 | |
| 7,152,000 | |
| 5,640,000 | |
| 5,669,000 | |
| 5,758,000 | |
| 5,922,000 | |
| 4,699,000 | |
| 4,465,000 | |
| 4,359,000 | |
| 0 | |
| 3,837,000 | |
| 3,008,000 | |
| 0 | |
| 667,000 | |
| 456,000 | |
| 271,000 | |
| 126,000 | |
| 109,000 | |
| 105,000 |